Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. is a digital asset treasury company headquartered in New York, New York. Its core business revolves around accumulating, managing, and optimizing HYPE tokens, the native digital asset of the Hyperliquid Layer-1 blockchain. The company's mission is to maximize shareholder value by providing capital-efficient and productive access to the HYPE token for U.S. and institutional investors.

Hyperliquid Strategies Inc. engages in various activities within the Hyperliquid ecosystem, including staking HYPE tokens to generate compounding returns, yield optimization, and active ecosystem engagement. The company also operates a validator on the Hyperliquid network. While it previously held a subsidiary, Sonnet BioTherapeutics Holdings, Inc., an oncology-focused biotechnology company, Hyperliquid Strategies Inc. is actively winding down these legacy biotech operations to concentrate on its digital asset strategy.

Led by CEO David Schamis, Hyperliquid Strategies Inc. is publicly traded on NASDAQ under the ticker PURR, having gone public in December 2025 through a business combination. The company has recently expanded its equity financing facility with Chardan Capital Markets to $2.5 billion in September 2026, and reported significant growth in its HYPE treasury for the fiscal year ended June 30, 2026. Hyperliquid Strategies Inc. is positioned as the largest HYPE-focused digital asset treasury, and its stock has seen substantial gains, reflecting its concentrated exposure to the Hyperliquid ecosystem.